These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37359014)

  • 61. Prospective comparison of new Japanese Association for Acute Medicine (JAAM) DIC and International Society of Thrombosis and Hemostasis (ISTH) DIC score in critically ill septic patients.
    Singh RK; Baronia AK; Sahoo JN; Sharma S; Naval R; Pandey CM; Poddar B; Azim A; Gurjar M
    Thromb Res; 2012 Apr; 129(4):e119-25. PubMed ID: 22138415
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Risk Benefit Analysis in Reference to use of LMWH in COVID-19.
    Samajdar SS; Sam PA; Moitra S; Ray Y; Pal J; Joshi SR; Tripathi SK
    J Assoc Physicians India; 2020 Sep; 68(9):52-61. PubMed ID: 32798346
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy.
    Spyropoulos AC; Frost FJ; Hurley JS; Roberts M
    Chest; 2004 May; 125(5):1642-50. PubMed ID: 15136371
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Disseminated Intravascular Coagulopathy in Critically Ill Patients in Amman, Jordan.
    Emleek EMQ; Khalil AA
    Biol Res Nurs; 2021 Oct; 23(4):689-697. PubMed ID: 34030507
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Heparin therapy in sepsis and sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis.
    Totoki T; Koami H; Makino Y; Wada T; Ito T; Yamakawa K; Iba T
    Thromb J; 2024 Sep; 22(1):84. PubMed ID: 39350146
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effectiveness of low-molecular-weight heparin versus unfractionated heparin to prevent pulmonary embolism following major trauma: A propensity-matched analysis.
    Byrne JP; Geerts W; Mason SA; Gomez D; Hoeft C; Murphy R; Neal M; Nathens AB
    J Trauma Acute Care Surg; 2017 Feb; 82(2):252-262. PubMed ID: 27906870
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sepsis-Induced Coagulopathy and Japanese Association for Acute Medicine DIC in Coagulopathic Patients with Decreased Antithrombin and Treated by Antithrombin.
    Iba T; Arakawa M; Levy JH; Yamakawa K; Koami H; Hifumi T; Sato K
    Clin Appl Thromb Hemost; 2018 Oct; 24(7):1020-1026. PubMed ID: 29695178
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Combined prognostic value of serum lactic acid, procalcitonin and severity score for short-term prognosis of septic shock patients].
    Hao C; Hu Q; Zhu L; Xu H; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):281-285. PubMed ID: 33834968
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Highlighting the potential of heparin in the treatment of sepsis in view of failure of KyberSept and OPTIMIST projects].
    Lin HY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):134-7. PubMed ID: 17376263
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Validation of Two Revised, Simplified Criteria for Assessing Sepsis-Associated Disseminated Intravascular Coagulation in ICU Patients with Sepsis-3: A Retrospective Study.
    Wang B; Zhang B; Shen Y; Li J; Yuan X; Tang N
    Lab Med; 2023 May; 54(3):291-298. PubMed ID: 36239637
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [A multicenter confirmatory study about precision and practicability of Sepsis-3].
    Hu X; Wu M; Fang Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):99-105. PubMed ID: 28625254
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Home versus in-patient treatment for deep vein thrombosis.
    Othieno R; Okpo E; Forster R
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD003076. PubMed ID: 29315455
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Optimal Timing and Early Intervention With Anticoagulant Therapy for Sepsis-Induced Disseminated Intravascular Coagulation.
    Yamakawa K; Umemura Y; Murao S; Hayakawa M; Fujimi S
    Clin Appl Thromb Hemost; 2019; 25():1076029619835055. PubMed ID: 30841721
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Assessment values of procalcitonin, lactic acid, and disease severity scores in patients with sepsis].
    Wang J; Wang H; Liu W; Zhang D; Guo S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Aug; 31(8):938-941. PubMed ID: 31537215
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Association of Low Molecular Weight Heparin Use and In-hospital Mortality Among Patients Hospitalized with COVID-19.
    Shen L; Qiu L; Liu D; Wang L; Huang H; Ge H; Xiao Y; Liu Y; Jin J; Liu X; Wang DW; Peterson ED; He B; Zhou N
    Cardiovasc Drugs Ther; 2022 Feb; 36(1):113-120. PubMed ID: 33394360
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
    Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
    Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sepsis-Induced Coagulopathy Score is Associated with an Increased Risk of New-Onset Atrial Fibrillation in Septic Patients: A Two-Centered Retrospective Study.
    Li J; Wang S; Ma C; Ning N; Huang Y; Jiao M; Zhang J; Sun W; Li J; Zhao B; Mao E; Che Z; Gao C
    J Inflamm Res; 2024; 17():5889-5899. PubMed ID: 39228679
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation.
    Slofstra SH; van 't Veer C; Buurman WA; Reitsma PH; ten Cate H; Spek CA
    Crit Care Med; 2005 Jun; 33(6):1365-70. PubMed ID: 15942357
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Independent risk factors for COVID-19-associated coagulopathy.
    Tor YB; Ozbalak M; Kalayoglu-Besisik S; Aksoy E; Cagatay AA; Gul A; Erelel M; Senkal N; Medetalibeyoglu A; Kose M; Tukek T
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7851-7860. PubMed ID: 37667962
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study.
    Koyama K; Madoiwa S; Nunomiya S; Koinuma T; Wada M; Sakata A; Ohmori T; Mimuro J; Sakata Y
    Crit Care; 2014 Jan; 18(1):R13. PubMed ID: 24410881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.